Seer is a proteomics company helping researchers investigate biological complexity through deep, unbiased protein analysis at scale. Its Proteograph Product Suite is designed to support rapid discovery across human and nonhuman sample types, including plasma, with broad protein and peptide coverage. Seer reports that the platform detects more than 36,000 proteins and over 300,000 peptides, and provides insights spanning more than 1,900 biological pathways. The company positions its technology for scientific discovery and pharma and biopharma research, including work to expand understanding of plasma proteomics and support drug development.

Researchers can access the Proteograph Product Suite in several ways: bring the system in-house, run a project at Seer’s Technology Access Center, or work with a Seer service provider or Center of Excellence. Seer also offers educational and research resources, including publications, webinars, technical downloads, a protein discovery catalog, and its Seer Insights Program. Through its products, access options, and scientific resources, Seer aims to help teams generate detailed proteomic evidence for biological research.